The Leukemia & Lymphoma Society has awarded forty-one grants totaling $24 million in support of blood cancer research.
Through its Translational Research Program, the organization awarded twenty-one three-year grants of $600,000 in support of projects aimed at accelerating the development of promising discoveries in critical areas of unmet cancer research. In addition, it awarded twenty grants totaling $11.4 million to scientists working in other areas of blood cancer research.
"The translation of research discoveries in the laboratory to the patient's bedside for the treatment of blood cancer is a central part of the mission of LLS," said Lee Greenberger, Ph.D, the organization's chief scientific officer. "By taking a strategic, proactive approach, LLS is directing grant funds with the intent to accelerate the advancement of breakthrough therapies and provide the best quality of life for our patients."